The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-chloro-5-(5-((3-oxobenzo[b]thiophen-2(3H)-ylidene)methyl)furan-2-yl)benzoic acid ID: ALA4790102
PubChem CID: 1824858
Max Phase: Preclinical
Molecular Formula: C20H11ClO4S
Molecular Weight: 382.82
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1cc(-c2ccc(/C=C3\Sc4ccccc4C3=O)o2)ccc1Cl
Standard InChI: InChI=1S/C20H11ClO4S/c21-15-7-5-11(9-14(15)20(23)24)16-8-6-12(25-16)10-18-19(22)13-3-1-2-4-17(13)26-18/h1-10H,(H,23,24)/b18-10-
Standard InChI Key: ZPWFYRKGVDZJMU-ZDLGFXPLSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
0.6135 -7.6807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6124 -8.5003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3204 -8.9092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3187 -7.2719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0273 -7.6771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0275 -8.5003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8105 -8.7545 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.2942 -8.0883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8101 -7.4226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0624 -6.6453 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1114 -8.0881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5202 -8.7956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1849 -9.5397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7924 -10.0863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5000 -9.6774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3297 -8.8782 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2043 -10.0843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2041 -10.9026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9116 -11.3101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6197 -10.9005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6159 -10.0791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9079 -9.6752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3229 -9.6664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0326 -10.0715 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3188 -8.8492 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3285 -11.3071 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
9 10 2 0
8 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 12 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
15 17 1 0
23 24 1 0
23 25 2 0
21 23 1 0
20 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 382.82Molecular Weight (Monoisotopic): 382.0067AlogP: 5.63#Rotatable Bonds: 3Polar Surface Area: 67.51Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 2.94CX Basic pKa: ┄CX LogP: 4.57CX LogD: 1.08Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.59Np Likeness Score: -1.24
References 1. Hou X,Sun JP,Ge L,Liang X,Li K,Zhang Y,Fang H. (2020) Inhibition of striatal-enriched protein tyrosine phosphatase by targeting computationally revealed cryptic pockets., 190 [PMID:32078861 ] [10.1016/j.ejmech.2020.112131 ] 2. Lazinski LM, Royal G, Robin M, Maresca M, Haudecoeur R.. (2022) Bioactive Aurones, Indanones, and Other Hemiindigoid Scaffolds: Medicinal Chemistry and Photopharmacology Perspectives., 65 (19.0): [PMID:36126323 ] [10.1021/acs.jmedchem.2c01150 ]